NEW YORK (GenomeWeb News) – Direct-to-consumer genetic testing firm 23andMe announced several new appointments to its executive team, including Christine Castro as VP of communications, Neil Rothstein as VP of marketing, and Jonathan Ward as VP of strategic alliances.
Before joining 23andMe, Castro was VP of corporate relations at Genentech, chief communications officer for Yahoo!, and VP of corporate communications at The Walt Disney Company.
Rothstein worked at Netflix for 11 years before coming to 23andMe. Most recently, he served as VP of online marketing at Netflix.
Ward was interim chief marketing officer at eHarmony.com before coming to 23andMe and has held marketing and business development positions at America Online, McKinsey & Company, as well as Ogilvy, Adams & Rinehart.
Caprotec Bioanalytics has appointed Jonathan Turner to be CEO and managing director. Turner will take over the CEO spot from company founder Hubert Koester, who will continue to work with the company as acting chief scientific officer and chairman of the scientific advisory board.
Turner formerly was senior VP at XL Techgroup, a technology developer and equity firm, and he held senior management posts at Boehringer Ingelheim, Astrazeneca, and Schering.
BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.
Abdalian most recently was VP and CFO at Knome, and he has been CEO at Pelias Technologies and CFO at Molecular Insight Pharmaceutical Group and Emisphere Technologies.
Karl Winkler has been tapped to oversee Anagnostics' sales and customer support efforts, the St. Valentin, Austria-based firm said this week.
In his new position, Winkler will focus on direct sales to hospitals in Austria, Germany, and the German-speaking areas of Switzerland. He previously held similar positions at Heinen & Loewenstein and Messer Medical Austria, Anagnostics said.
Patrick Terry this week announced he is leaving consulting firm Scientia Advisors, where he was head of the pricing, reimbursement, and market access practice.
Upon his departure from Scientia, Terry plans to take some personal time, and then depart for a speaking tour through China in November. Hebei United University in Tangshan, China, has awarded Terry with an honorary post as professor of medical sciences. Terry will be speaking throughout the country about personalized medicine.
Terry is best known for having started a number of life sciences-focused organizations and companies. In 2000 he was among a group of life sciences leaders that founded the molecular diagnostics firm Genomic Health.
Terry plans to return to founding and investing in new healthcare and technology companies.
The Institute of Medicine of the National Academy of Sciences has elected 70 new members including Lynda Chin, Stephen Quake, and Daniel Kastner.
Chin is currently a professor and chair of genomic medicine and scientific director of the Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center. She also serves in a leadership role for the Cancer Genome Atlas and the International Cancer Genome Consortium.
Quake is a professor of bioengineering at Stanford University and an investigator at the Howard Hughes Medical Institute. He has developed technology for next-generation sequencing, including single-molecule sequencing and single-cell sequencing, and has licensed technology for the detection of fetal aneuploidies in maternal plasma to Verinata Health.
Kastner is the scientific director of the National Human Genome Research Institute, where, among other duties, he leads the inflammatory disease section of the medical genetics branch.
The University of Pittsburgh said this week that Jeffrey Kant died on Sept. 29 at the age of 65.
Kant was director of the University of Pittsburgh Medical College's Department of Molecular Diagnostics and a professor pathology and human genetics at UPMC.
Kant had a long career in molecular diagnostics and human genetics, he established one of the first molecular diagnostics labs in a pathology department, and he was "instrumental" in the formation of the Association for Molecular Pathology, Pitt said.
He also received the Lifetime Achievement Award from the College of American Pathologists this year, he was the first recipient of AMP's leadership award, and he contributed to dozens of published papers and served on the editorial boards of several journals.
The Genetics Society of America has awarded its 2013 GSA awards to genetics researchers Elaine Ostrander and A. Malcolm Campbell.
Ostrander was awarded the Genetics Society of America Medal for her work in prostate and breast cancer as well as canine genomics, including leading the effort to sequence the dog genome. Ostrander is the chief of the cancer genetics branch, head of the comparative genetics section, and a National Institutes of Health distinguished investigator at the National Human Genome Research Institute.
Campbell was awarded the Elizabeth W. Jones Award for Excellence in Education for his work on bringing genomics into undergraduate education at Davidson College. He is a co-author of one of the first genomics textbooks for undergraduates — Genomics, Proteomics, and Bioinformatics — and developed the Genome Consortium for Active Teaching. He has also brought next-gen sequencing to undergrads.
Campbell is a professor of biology and director of the James G. Martin Genomics Program at Davidson.
Louis Silverman has joined LifeMap Sciences' board of directors. Silverman formerly was CEO at Marina Medical Billing Service, president and CEO of Lifecomm, president and CEO of Quality Systems, and he served as chief operations officer at Corvel.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.